Q2 2014

Source filing unavailable

Q2 2014 · —

Revenue

$5.74M

no prior Q2 2013 on file

Net Income

$11.81M

N/M vs Q2 2013

EPS Diluted

-$0.77

N/M vs Q2 2013

Operating Income-$17,182,000N/M

Operating Cash Flowderived-$11,449,715—

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	$5.74M	—	$0.00	$0.00
Net Income	$11.81M	-$4.92M	-$3.50K	-$3.53K
EPS Diluted	-$0.77	-$0.41	—	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR